BPC-157 + TB-500 Capsules: Blend Options

Those searching for BPC-157 TB-500 capsules will find very limited availability. As of October 2026, none of the notable peptide suppliers we know of have any combined package of BPC-157 and TB-500 available. The combination is present only in the form of lyophilized vial prepared by PeptideGod, and there are hardly any documented capsules on the market. This article discusses the present status, reasons why such combination is difficult to manufacture, and the other alternatives that are available.

Current Availability of BPC-157 + TB-500 Capsules

PeptideGod offers their BPC-157 + TB-500 blend as a vial of lyophilized peptide priced at $59.95. It is not a capsule form of dosage. It needs to be reconstituted with bacteriostatic water. PeptideGod does not sell any capsule forms.

Real Peptides sells BPC-157 capsules at 500 mcg each. They do not sell a TB-500 capsule or a combined BPC-157 + TB-500 capsule product. Their BPC-157 capsules contain only the single peptide.

Why Capsule Blends Are Uncommon

TB-500 and Oral Stability

BPC-157's acid stability is well documented. It survives pH 1-2 for over 24 hours in laboratory conditions (Sikiric et al., 2011). TB-500, a synthetic fragment of Thymosin Beta-4, does not have the same body of stability research. Most published work on TB-500 uses injection as the route of administration. Whether TB-500 survives gastric acid degradation long enough for meaningful oral absorption is not established in the literature.

This creates an issue in formulating the product. By putting both peptides in a capsule, it is assumed that they can both be given orally. This is true for BPC-157, but not for TB-500. Any capsule formulation in which one of the peptides is broken down in the stomach while the other is intact will not provide the correct ratio of the two peptides.

Ratio and Dosing Complications

Even within PeptideGod's vial format, the ratio of BPC-157 to TB-500 has not been made available for review. This is also complicated by manufacturing capsules. Each capsule must be manufactured in a specific manner, where the amount of each peptide used is exactly as required and properly distributed throughout the filling. Also, when it comes to capsules containing several peptides, consistency is important, and such consistency can only be achieved through validated manufacturing. Without a COA confirming the content of each specific capsule, it is impossible to verify if batches based on the described formula are consistent.

What About Separate Capsules?

An alternative approach is taking BPC-157 capsules and TB-500 capsules separately. This gives control over the amount of each peptide. The problem is that standalone TB-500 capsule products with published analytical documentation are rare. Most TB-500 is sold as a lyophilized vial for reconstitution.

Using the Real Peptides BPC-157 capsules alongside a TB-500 vial means mixing delivery routes: oral for BPC-157, injection for TB-500. Researchers pursuing both peptides should weigh whether a consistent delivery route matters for their protocol.

The "Wolverine Stack" Marketing

PeptideGod has branded their BPC-157 + TB-500 product as the “Wolverine Stack” in a promotional move aimed at deriving comparisons from the regenerative capabilities of the character from the comic books. It refers to a synergism but is misleading since there are no studies that would confirm such claims. In clinical practice, there were no preclinical or clinical evaluations of this particular BPC-157 + TB-500 combination compared to each of those peptides being used on its own in controlled conditions.

Both of these peptides have been explored in laboratory animals separately. The BPC-157 peptide is known for the promotion of the healing properties of tissues as well as their protective properties. On the other hand, TB-500 is known for its healing effects on wounds as well as its anti-inflammatory effect. The assumption of the synergistic or additive effects of both peptides is nothing but just an assumption.

What to Look for if Capsule Blends Appear

If a vendor begins selling BPC-157 + TB-500 capsules, evaluate these points before purchasing:

• COA for both peptides: Does the Certificate of Analysis confirm the content of each peptide individually?
• Oral stability data for TB-500: Has the vendor or any published source confirmed that TB-500 survives gastric conditions?
• Per-capsule content: Are the milligram amounts of each peptide stated per capsule?
• Salt form disclosure: Is the label clear about whether the stated weight includes counter-ions?
• Purity percentage: HPLC verification for each peptide, not just the blend total?

Until a product meets these standards, the documented capsule option remains single-peptide BPC-157 from vendors with published testing. See our brands page for the full vendor comparison.